# \[e-drug\] Time needed to provide bioequivalence studies **URL:** \ **Category:** e-drug\ **Created:** [October 8, 2001, 9:24pm UTC](https://talk.edrugplus.org/t/e-drug-time-needed-to-provide-bioequivalence-studies/12633 "2001-10-08T21:24:02Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![love](https://avatars.discourse-cdn.com/v4/letter/l/dec6dc/32.png) [@love](https://talk.edrugplus.org/u/love)\ **Post date:** [October 8, 2001, 9:24pm UTC](https://talk.edrugplus.org/t/e-drug-time-needed-to-provide-bioequivalence-studies/12633/1 "2001-10-08T21:24:02Z")
E-drug: Time needed to provide bioequivalence studies ------------------------------------------------------------------------- I would appreciate information on the amount of time that is normally required for generic companies to conduct and organize the various bioequivalence studies required for drug registration in Europe, the United States, Canada, Australia or South Africa. Jamie James Love Consumer Project on Technology [http://www.cptech.org](http://www.cptech.org) 1.202.380.3080 fax 1.202.234.5176 [mailto:love@cptech.org](mailto:love@cptech.org) -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Information and archive [http://satellife.healthnet.org/programs/edrug.html](http://satellife.healthnet.org/programs/edrug.html) Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.